Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model

Figure 7

Gd concentrations in major brain areas with Gd retention in normal and diabetic rats after multiple injections of gadodiamide, gadopentetate dimeglumine, and gadoterate meglumine. (a-c) Gd concentrations in the olfactory bulb, DCN, and striatum of normal rats. (d-f) Gd concentrations in the olfactory bulb, DCN, and striatum of diabetic rats. All the data are expressed as the means ± SD ( p < 0.05; p < 0.01).

(a)

(b)

(c)

(d)

(e)

(f)